182 related articles for article (PubMed ID: 38353382)
1. Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.
Pang N; Tudahong S; Zhu Y; He J; Han C; Chen G; Wang W; Wang J; Ding J
Immun Inflamm Dis; 2024 Feb; 12(2):e1177. PubMed ID: 38353382
[TBL] [Abstract][Full Text] [Related]
2. The level of Tim-3+CD8+ T cells can serve as a potential marker for evaluating the severity of acute graft-versus-host disease after haplo-PBSCT.
Pang N; Yu M; Xu J; Yuan H; Chen G; Wang D; Han C; Wang W; Ding J; Jiang M
Braz J Med Biol Res; 2023; 56():e12997. PubMed ID: 38126537
[TBL] [Abstract][Full Text] [Related]
3. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
4. ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zhao Y; Zheng X; Li M; Zhao J; Wang X; Zhu H
Int Immunopharmacol; 2023 Feb; 115():109620. PubMed ID: 36577155
[TBL] [Abstract][Full Text] [Related]
5. The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
Ding L; Zhu H; Yang Y; Yan HM; Zhang HH; Han DM; Wang ZD; Zheng XL; Liu J; Zhu L; Mei-Xue ; Guo ZK; Wang HX
Leuk Res; 2017 May; 56():13-20. PubMed ID: 28161606
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
Front Immunol; 2018; 9():669. PubMed ID: 29740427
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation].
Niu YY; Ma LM; Zhou Y; Ren RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):735-9. PubMed ID: 20561440
[TBL] [Abstract][Full Text] [Related]
8. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
[TBL] [Abstract][Full Text] [Related]
9. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
Front Immunol; 2021; 12():647894. PubMed ID: 34262560
[TBL] [Abstract][Full Text] [Related]
10. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
[TBL] [Abstract][Full Text] [Related]
11. [Adipose-derived stem cell-derived exosomes regulate Th2/Treg balance in peripheral blood of AR patients through the mTOR pathway].
Han F; Xu X; Wang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 38(2):140-145. PubMed ID: 38297868
[No Abstract] [Full Text] [Related]
12. [Prediction of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation by the level of galectin-9 in peripheral blood].
Yin J; Cao Y; Zhou JF; Zhang YC
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):23-27. PubMed ID: 32023750
[No Abstract] [Full Text] [Related]
13. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.
Visentainer JE; Lieber SR; Persoli LB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA
Exp Hematol; 2003 Nov; 31(11):1044-50. PubMed ID: 14585368
[TBL] [Abstract][Full Text] [Related]
14. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
[TBL] [Abstract][Full Text] [Related]
15. [The role of Tim-3 mRNA in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Li XL; Yao Y; Yang BY; Xu LJ; Liu B; Che M; Zhu YB; Wu XJ; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):469-73. PubMed ID: 27431070
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between the methylation status of STAT3 promoter DNA in peripheral blood CD4+ T cells from patients after allo-HSCT and aGVHD].
Xu Y; Zhang Y; Chen Y; Fu B; Yang J; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):911-918. PubMed ID: 28872082
[TBL] [Abstract][Full Text] [Related]
17. [SIRT1 deficiency in CD4+T cells induces acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Zhang Y; Yang J; Zhang G; Peng J; Chen X; Chen F; Xu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):697-703. PubMed ID: 30124203
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Yao Y; Wang L; Zhou J; Zhang X
J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
[TBL] [Abstract][Full Text] [Related]
19. [Reconstitution kinetics of T helper cells subsets post unmanipulated allogeneic blood and marrow transplantation].
Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):745-50. PubMed ID: 24103870
[TBL] [Abstract][Full Text] [Related]
20. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]